Institute Of Diabetes Endocrinology And Adiposity Private Limited - Company Profile

It is a healthcare private limited company based in Hyderabad, Telangana, India, established in 2014.
2014 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Institute Of Diabetes Endocrinology And Adiposity Private Limited

Institute Of Diabetes Endocrinology And Adiposity Private Limited, a active private limited company, was established on 05 November 2014 in Hyderabad, Telangana, India. Engaging in diabetes care & endocrinology clinics within the hospital and medical care sector, it holds CIN: U85100TG2014PTC096244. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹1.45 Cr.

It upholds a compliant status. Its leadership includes Shyam Sunder Kalavalapalli (Director), Durga Bhavani Kalavalapalli (Director), Srinivas Rao Paidipally (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.16, Vikaspuri S R Nagar Post, Hyderabad, Telangana, 500038.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100TG2014PTC096244

  • Registration Number

    096244

  • Incorporation Date

    05 November 2014

  • Authorized Capital

    ₹2.50 Cr

  • Paid-Up Capital

    ₹1.45 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 Cr
  • Paid Up Capital ₹ 1.45 Cr
  • Company Age 11 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -9.27%
  • Profit Growth **** -32.28%
  • Ebitda **** -38.29%
  • Net Worth -59.54%
  • Total Assets -53.80%
Company report

Institute Of Diabetes Endocrinology And Adiposity Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Institute Of Diabetes Endocrinology And Adiposity Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Institute Of Diabetes Endocrinology And Adiposity Private Limited?
Current Directors
Name Designation Appointment Date Status
Shyam Sunder Kalavalapalli Director 05 Nov 2014 Current
Durga Bhavani Kalavalapalli Director 05 Nov 2014 Current
Srinivas Rao Paidipally Director 05 Nov 2014 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Institute Of Diabetes Endocrinology And Adiposity.

Institute Of Diabetes Endocrinology And Adiposity Private Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 9.27% decrease. The company also saw a substantial fall in profitability, with a 32.28% decrease in profit. The company's net worth observed a substantial decline by a decrease of 59.54%.

Institute Of Diabetes Endocrinology And Adiposity revenue growth over time
Institute Of Diabetes Endocrinology And Adiposity profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -9.27%
*******
*******
*******
*******
Revenue from Operations
*******
 -13.82%
*******
*******
*******
*******
Total Assets
*******
 -53.80%
*******
*******
*******
*******
Profit or Loss
*******
 -32.28%
*******
*******
*******
*******
Net Worth
*******
 -59.54%
*******
*******
*******
*******
EBITDA
*******
 -38.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Institute Of Diabetes Endocrinology And Adiposity?

In 2018, Institute Of Diabetes Endocrinology And Adiposity had a promoter holding of 86.11% and a public holding of 13.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Institute Of Diabetes Endocrinology And Adiposity?

Unlock and access historical data on people associated with Institute Of Diabetes Endocrinology And Adiposity, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Institute Of Diabetes Endocrinology And Adiposity, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Institute Of Diabetes Endocrinology And Adiposity's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Institute Of Diabetes Endocrinology And Adiposity
Recent Activity within the Organization
  • Annual General Meeting

    The activity Institute Of Diabetes Endocrinology And Adiposity Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Institute Of Diabetes Endocrinology And Adiposity Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Shyam Sunder Kalavalapalli was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Durga Bhavani Kalavalapalli was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 3 months . was documented.

  • Director Appointment

    The activity Srinivas Rao Paidipally was appointed as a Director was appointed as a Director on 05 Nov 2014 & has been associated with this company since 11 years 3 months . was completed.

  • Company Incorporation

    Progress on Institute Of Diabetes Endocrinology And Adiposity Private Limited was registered on 05 Nov 2014 with Roc Hyderabad & aged 11 years 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Institute Of Diabetes Endocrinology And Adiposity Private Limited?

The CIN of Institute Of Diabetes Endocrinology And Adiposity Private Limited is U85100TG2014PTC096244.

Where is Institute Of Diabetes Endocrinology And Adiposity Private Limited headquartered?

Institute Of Diabetes Endocrinology And Adiposity Private Limited is headquartered at No.16, Vikaspuri S R Nagar Post, Hyderabad, Telangana, 500038.

When was Institute Of Diabetes Endocrinology And Adiposity Private Limited incorporated?

Institute Of Diabetes Endocrinology And Adiposity Private Limited was incorporated on 05 November 2014.

Who are the current directors of Institute Of Diabetes Endocrinology And Adiposity Private Limited?

The current directors of Institute Of Diabetes Endocrinology And Adiposity Private Limited are

What is the primary industry of Institute Of Diabetes Endocrinology And Adiposity Private Limited?

The primary industry of Institute Of Diabetes Endocrinology And Adiposity Private Limited is Hospital And Medical Care.

Is Institute Of Diabetes Endocrinology And Adiposity Private Limited a listed company?

Institute Of Diabetes Endocrinology And Adiposity Private Limited is unlisted.

What is the capital structure of Institute Of Diabetes Endocrinology And Adiposity Private Limited?

The authorized capital of Institute Of Diabetes Endocrinology And Adiposity Private Limited is ₹2.50 Cr, and the paid-up capital is ₹1.45 Cr.

What is the compliance status of Institute Of Diabetes Endocrinology And Adiposity Private Limited?

The compliance status of Institute Of Diabetes Endocrinology And Adiposity Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available